These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10965494)

  • 1. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
    O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
    Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
    Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
    Pastore L; Morral N; Zhou H; Garcia R; Parks RJ; Kochanek S; Graham FL; Lee B; Beaudet AL
    Hum Gene Ther; 1999 Jul; 10(11):1773-81. PubMed ID: 10446917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
    Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
    Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery.
    O'Neal WK; Zhou H; Morral N; Aguilar-Cordova E; Pestaner J; Langston C; Mull B; Wang Y; Beaudet AL; Lee B
    Hum Gene Ther; 1998 Jul; 9(11):1587-98. PubMed ID: 9694157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.
    Morral N; Parks RJ; Zhou H; Langston C; Schiedner G; Quinones J; Graham FL; Kochanek S; Beaudet AL
    Hum Gene Ther; 1998 Dec; 9(18):2709-16. PubMed ID: 9874269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy.
    Brunetti-Pierri N; Stapleton GE; Palmer DJ; Zuo Y; Mane VP; Finegold MJ; Beaudet AL; Leland MM; Mullins CE; Ng P
    Mol Ther; 2007 Apr; 15(4):732-40. PubMed ID: 17285138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
    Parks R; Evelegh C; Graham F
    Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper-dependent adenoviral vectors for gene therapy.
    Palmer DJ; Ng P
    Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
    Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
    Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in helper-dependent adenoviral vector research.
    Segura MM; Alba R; Bosch A; Chillón M
    Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
    Brunetti-Pierri N; Ng P
    Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
    Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
    Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver.
    McCaffrey AP; Fawcett P; Nakai H; McCaffrey RL; Ehrhardt A; Pham TT; Pandey K; Xu H; Feuss S; Storm TA; Kay MA
    Mol Ther; 2008 May; 16(5):931-41. PubMed ID: 18388926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
    Seiler MP; Cerullo V; Lee B
    Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of helper-dependent adenoviral vectors by homologous recombination.
    Toietta G; Pastore L; Cerullo V; Finegold M; Beaudet AL; Lee B
    Mol Ther; 2002 Feb; 5(2):204-10. PubMed ID: 11829528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.
    Mane VP; Toietta G; McCormack WM; Conde I; Clarke C; Palmer D; Finegold MJ; Pastore L; Ng P; Lopez J; Lee B
    Gene Ther; 2006 Sep; 13(17):1272-80. PubMed ID: 16708078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.
    Unzu C; Melero I; Hervás-Stubbs S; Sampedro A; Mancheño U; Morales-Kastresana A; Serrano-Mendioroz I; de Salamanca RE; Benito A; Fontanellas A
    Gene Ther; 2015 Nov; 22(11):856-65. PubMed ID: 26125605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.